The utility of acute physiology and chronic health evaluation II scores for prediction of mortality among intensive care unit (ICU) and non-ICU patients with methicillin-resistant Staphylococcus aureus bacteremia

scientific article published on 13 April 2012

The utility of acute physiology and chronic health evaluation II scores for prediction of mortality among intensive care unit (ICU) and non-ICU patients with methicillin-resistant Staphylococcus aureus bacteremia is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1086/665731
P698PubMed publication ID22561710

P50authorVanessa StevensQ40599481
Jack BrownQ79916563
Elizabeth Dodds AshleyQ87278947
P2093author name stringAlan Forrest
Kristen Brown
Thomas P Lodise
Brian Tsuji
Jill Butterfield
Meagan Stringham
P2860cites workGuidelines for the Management of Adults with Hospital-acquired, Ventilator-associated, and Healthcare-associated PneumoniaQ22241905
A comparison of Child-Pugh, APACHE II and APACHE III scoring systems in predicting hospital mortality of patients with liver cirrhosisQ24801095
Severity scoring in the ICU: a reviewQ28272581
The meaning and use of the area under a receiver operating characteristic (ROC) curveQ29547182
APACHE II: a severity of disease classification systemQ29547729
Comparing the areas under two or more correlated receiver operating characteristic curves: a nonparametric approachQ29614698
A chronic disease score from automated pharmacy dataQ30983653
Nonexperimental comparative effectiveness research using linked healthcare databasesQ33576469
Derivation and validation of an index to predict early death or unplanned readmission after discharge from hospital to the communityQ33753809
Instrumental variable methods in comparative safety and effectiveness researchQ33915337
Use of comorbidity scores for control of confounding in studies using administrative databasesQ34062587
Outcome and attributable mortality in critically Ill patients with bacteremia involving methicillin-susceptible and methicillin-resistant Staphylococcus aureus.Q34155402
The impact of methicillin resistance in Staphylococcus aureus bacteremia on patient outcomes: mortality, length of stay, and hospital chargesQ34401421
Development and validation of the mortality risk for trauma comorbidity indexQ34574111
Quantifying risk and benchmarking performance in the adult intensive care unitQ36847059
Controlling for severity of illness in outcome studies involving infectious diseases: impact of measurement at different time pointsQ37275990
Treatment of candidemia and invasive candidiasis in the intensive care unit: post hoc analysis of a randomized, controlled trial comparing micafungin and liposomal amphotericin B.Q37443139
Confounding control in healthcare database research: challenges and potential approaches.Q39700269
Fever in liver transplant recipients in the intensive care unit.Q40628319
Comparison of the rapid emergency medicine score and APACHE II in nonsurgical emergency department patientsQ42034036
Risk factors and predictors of mortality of methicillin-resistant Staphylococcus aureus (MRSA) bacteraemia in HIV-infected patientsQ44121037
Admission lactate level and the APACHE II score are the most useful predictors of prognosis following torso traumaQ44972738
Risk factors for hematogenous complications of intravascular catheter-associated Staphylococcus aureus bacteremiaQ45268073
Improved prediction of outcome in patients with severe acute pancreatitis by the APACHE II score at 48 hours after hospital admission compared with the APACHE II score at admission. Acute Physiology and Chronic Health EvaluationQ46698700
Comparison of Acute Physiology and Chronic Health Evaluation (APACHE) II score with organ failure scores to predict hospital mortalityQ48604605
Predictors of 6-month mortality in elderly patients with mild chronic obstructive pulmonary disease discharged from a medical ward after acute nonacidotic exacerbation.Q50778308
P433issue6
P921main subjectStaphylococcus aureusQ188121
methicillin-resistant Staphylococcus aureusQ595158
intensive care unitQ5094647
P304page(s)558-564
P577publication date2012-04-13
P1433published inInfection Control and Hospital EpidemiologyQ6029185
P1476titleThe utility of acute physiology and chronic health evaluation II scores for prediction of mortality among intensive care unit (ICU) and non-ICU patients with methicillin-resistant Staphylococcus aureus bacteremia
P478volume33

Reverse relations

cites work (P2860)
Q35028914Candidemia in the critically ill: initial therapy and outcome in mechanically ventilated patients
Q34298840Case-case-control study of patients with carbapenem-resistant and third-generation-cephalosporin-resistant Klebsiella pneumoniae bloodstream infections
Q41105794Development of a mortality prediction formula due to sepsis/severe sepsis in a medical intensive care unit
Q40328540Double-carbapenem combination as salvage therapy for untreatable infections by KPC-2-producing Klebsiella pneumoniae
Q36439114Ertapenem-Containing Double-Carbapenem Therapy for Treatment of Infections Caused by Carbapenem-Resistant Klebsiella pneumoniae
Q89846157Evaluation of the INCREMENT-CPE, Pitt Bacteremia and qPitt Scores in Patients with Carbapenem-Resistant Enterobacteriaceae Infections Treated with Ceftazidime-Avibactam
Q33909393ICG-liver test versus new biomarkers as prognostic markers for prolonged length of stay in critically ill patients - a prospective study of accuracy for prediction of length of stay in the ICU.
Q37613052Multicenter Observational Study of Ceftaroline Fosamil for Methicillin-Resistant Staphylococcus aureus Bloodstream Infections
Q45714507Performance of clinical scoring systems in acute organophosphate poisoning.
Q40478665Pharmacist-managed dose adjustment feedback using therapeutic drug monitoring of vancomycin was useful for patients with methicillin-resistant Staphylococcus aureus infections: a single institution experience.
Q33843450Procalcitionin as a diagnostic marker to distinguish upper and lower gastrointestinal perforation
Q38690127Relationship between vancomycin exposure and outcomes among patients with MRSA bloodstream infections with vancomycin Etest® MIC values of 1.5mg/L: A pilot study
Q36494439Simplified risk stratification criteria for identification of patients with MRSA bacteremia at low risk of infective endocarditis: implications for avoiding routine transesophageal echocardiography in MRSA bacteremia.

Search more.